Denemek ALTIN - Özgür
Find X9 Series marks OPPO’s bold step into India’s premium smartphone segment
Mint New Delhi
|December 05, 2025
Peter Dohyung Lee, head of Product Strategy at OPPO, discusses the newly launched Find X9 Series, why India is a priority market, and the company’s future roadmap for the premium segment.
-
Peter Dohyung Lee, Head of Product Strategy, OPPO (centre), with other dignitaries launching the OPPO Find X9 Series in India.
Why is India an important market for OPPO?
India represents one of OPPO’s largest global markets and a powerful source of creative and cultural insight. The country’s vibrant ecosystem of creators, storytellers, and tech-forward consumers encourages us to push the boundaries of design, performance, and imaging innovation. Indian users are among the most expressive and experience-driven audiences we engage with, making India pivotal to OPPO’s premium growth vision. Today, OPPO holds the #2 position in the Indian smartphone market with a 13.9% share, underscoring the strength of our product strategy, channel excellence, and deep consumer trust.
What is OPPO's India product strategy built on?
Bu hikaye Mint New Delhi dergisinin December 05, 2025 baskısından alınmıştır.
Binlerce özenle seçilmiş premium hikayeye ve 9.000'den fazla dergi ve gazeteye erişmek için Magzter GOLD'a abone olun.
Zaten abone misiniz? Oturum aç
Mint New Delhi'den DAHA FAZLA HİKAYE
Mint New Delhi
Margin strain prompts wealth firms to expand
With a surge in affluent people, competition has intensified in the space
2 mins
December 10, 2025
Mint New Delhi
Govt picks fund managers for ₹1 tn deep-tech boost
DST has appointed BIRAC and TDB, and is set to add Sidbi and SBI Funds Management soon
2 mins
December 10, 2025
Mint New Delhi
Forgettable promos lead to ad fatigue for OTT viewers
Advertising on video-streaming services is increasingly resulting in viewer fatigue as platforms try to replace plateauing paid subscription revenue with ad money.
2 mins
December 10, 2025
Mint New Delhi
Novo moves HC to restrain Sun Pharma
As blockbuster weight loss drug semaglutide inches closer to losing its patent exclusivity in India, innovator Novo Nordisk is upping its ante against local firms wanting to launch copies of the drug.
1 mins
December 10, 2025
Mint New Delhi
Sibling disputes over residual assets: key principles explained
My father willed specific assets to my mother and me, and said any unspecified assets would go equally to my sister and me.
2 mins
December 10, 2025
Mint New Delhi
Healthcare to home repairs: how to plan for emergencies
More households are setting up dedicated reserve funds for unexpected, uninsured expenses
3 mins
December 10, 2025
Mint New Delhi
FIRs against Anil Ambani's son, group cos
The Central Bureau of Investigation (CBI) on Tuesday carried out searches at the residence of industrialist Anil Ambani’s son Jai Anmol Ambani in Mumbai after registering a case against him and a Reliance ADA Group company—Reliance Home Finance Ltd (RHFL) on a complaint of Union Bank of India, which alleged that a fraud of ₹2228 crore was committed against the bank.
1 mins
December 10, 2025
Mint New Delhi
Swiggy launches new share offering
Indian food delivery major Swiggy Ltd on Tuesday launched a new share offering for institutional investors to raise up to ₹10,000 crore ($1.1 billion), just a year after its market debut.
1 min
December 10, 2025
Mint New Delhi
PepsiCo agrees to pare its US lineup
PepsiCo Inc. reached an agreement with activist investor Elliott Investment Management to reduce its US product lineup by 20% and lower prices, while the company also pares its workforce.
1 min
December 10, 2025
Mint New Delhi
'Airlines' net profit likely $41 bn next yr'
Global airline trade body IATA said on Tuesday the airline sector would post record profits next year despite ongoing supply chain issues leading to slower aircraft deliveries and a delay in rolling out more fuel-efficient jets.
1 min
December 10, 2025
Listen
Translate
Change font size